Skip to content

Research on the Efficacy of Chinese-Style Body Shape Management Products

Research on the Efficacy of Chinese-Style Body Shape Management Products

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108154
Enrollment
Unknown
Registered
2025-08-26
Start date
2025-08-31
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity/Overweight

Interventions

Product Group A:Protein Plus + Type Beauty Probiotics + Yanggu Jian Changxinwei Oral Liquid Placebo
Product Group B:Protein Abundance + Type Beauty Probiotics + Yanggu Jian Changxinwei Oral Liquid

Sponsors

Beijing University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 49 Years

Inclusion criteria

Inclusion criteria: 1. Simple obese individuals who simultaneously meet the diagnostic criteria for phlegm-dampness constitution and overweight/obesity; 2. Age: 30 to 49 years old (inclusive); 3. Have resided locally for one year or more and will not leave the city in the next six months; 4. Waist circumference: Male >=90cm, female >=85cm; 5. Voluntarily participate in this study and sign the informed consent form

Exclusion criteria

Exclusion criteria: 1.Patients with severe diseases such as cardiovascular and cerebrovascular diseases, lung diseases, liver diseases, kidney diseases, endocrine system diseases, and malignant tumors who need to be managed in accordance with disease management methods; 2. Those with a history of gastrointestinal diseases or gastrointestinal surgery that may affect product absorption; 3. Patients with secondary obesity: those with hypothalamic syndrome, pituitary adenoma, Cushing's syndrome, hypothyroidism, hypogonadism, hyperadrenal insufficiency, etc. 4. Pregnant or lactating women; 5. Inability to cooperate, such as intellectual disability, mental or mental disorders, etc. 6. Those who are currently undergoing or have undergone other weight loss treatments in the past three months, including those taking weight loss drugs; Cases are excluded if any one or more of the above criteria are met.

Design outcomes

Primary

MeasureTime frame
Weight;BMI;Waist circumference;Hip circumference;Body fat percentage;Waist-to-hip ratio;Visceral fat area;

Secondary

MeasureTime frame
Quantitative scoring of phlegm-dampness constitution ;Biochemical indicators of blood tests: five lipid items, fasting blood glucose, glycated hemoglobin, C-reactive protein, tumor necrosis factor - a, interleukin-6, uric acid.;SF-36 Quality of Life Questionnaire;

Countries

China

Contacts

Public ContactLi Lingru

Beijing University of Chinese Medicine/National Research Center for Traditional Chinese

lilingru912@163.com+86 10 6428 6766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026